BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11391524)

  • 1. Partially reversible renal tubular damage in patients with obstructive jaundice.
    Bairaktari E; Liamis G; Tsolas O; Elisaf M
    Hepatology; 2001 Jun; 33(6):1365-9. PubMed ID: 11391524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the proximal tubular function in individuals with primary renal hypouricemia: an NMR-based metabonomic study.
    Tzovaras VT; Psychogios NG; Kostara CE; Bairaktari ET; Elisaf MS
    NMR Biomed; 2009 Dec; 22(10):1072-83. PubMed ID: 19593759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypouricemia in individuals admitted to an inpatient hospital-based facility.
    Bairaktari ET; Kakafika AI; Pritsivelis N; Hatzidimou KG; Tsianos EV; Seferiadis KI; Elisaf MS
    Am J Kidney Dis; 2003 Jun; 41(6):1225-32. PubMed ID: 12776275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salicylate-induced proximal tubular dysfunction.
    Tsimihodimos V; Psychogios N; Kakaidi V; Bairaktari E; Elisaf M
    Am J Kidney Dis; 2007 Sep; 50(3):463-7. PubMed ID: 17720526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal magnesium wasting and tubular dysfunction in leptospirosis.
    Khositseth S; Sudjaritjan N; Tananchai P; Ong-ajyuth S; Sitprija V; Thongboonkerd V
    Nephrol Dial Transplant; 2008 Mar; 23(3):952-8. PubMed ID: 17951309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative bile salt administration versus bile refeeding in obstructive jaundice.
    Tripathy U; Dhiman RK; Attari A; Katariya RN; Ganguly NK; Chawla YK; Dilawari JB
    Natl Med J India; 1996; 9(2):66-9. PubMed ID: 8857040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evidence of abnormal kidney processing of uric acid in patients with insulin-dependent diabetes mellitus].
    González-Sicilia de Llamas L; Lafuente López-Herrera M; Muñoz Sánchez JA; Martínez Marín A; Fernández Pardo J; Espi Martínez F
    Rev Clin Esp; 1990 Mar; 186(4):159-62. PubMed ID: 2367717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of low dose aspirin in elderly patients.
    Segal R; Lubart E; Leibovitz A; Iaina A; Caspi D
    Isr Med Assoc J; 2006 Oct; 8(10):679-82. PubMed ID: 17125112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypouricemia due to an isolated defect in renal tubular urate reabsorption.
    Fujiwara Y; Takamitsu Y; Ueda N; Orita Y; Abe H
    Clin Nephrol; 1980 Jan; 13(1):44-8. PubMed ID: 6988121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal handling of uric acid in man.
    Levinson DJ; Decker DE; Sorensen LB
    Ann Clin Lab Sci; 1982; 12(1):73-7. PubMed ID: 7065639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical aspects and renal function in patients with endemic nephropathy].
    Bukvić D; Djukanović L; Janković S
    Srp Arh Celok Lek; 2003; 131(1-2):10-6. PubMed ID: 14608855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlative urinary excretion of sodium-uric acid in hyperuricemia (author's transl)].
    Pérez Ortolá R; Picardo NG; Sánchez Palacios A
    Med Clin (Barc); 1980 Feb; 74(3):95-7. PubMed ID: 7366280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 May; 358():1-142. PubMed ID: 12695783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. J-shaped mortality relationship for uric acid in CKD.
    Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
    Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal handling of urate during water immersion in the nephrotic syndrome.
    Berlyne GM; Sutton J; Brown C; Caruso C; Friedman EA
    Miner Electrolyte Metab; 1984; 10(4):259-62. PubMed ID: 6749072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile salts, endotoxin and renal function in obstructive jaundice.
    Cahill CJ; Pain JA; Bailey ME
    Surg Gynecol Obstet; 1987 Dec; 165(6):519-22. PubMed ID: 3120329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.